Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Josh Wolfe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Column Group IV GP, LP - $39.15M in EIKN purchases and sales in the last 12 months
- Lux Venture Partners V, LLC - $5.00M in EIKN purchases and sales in the last 12 months
- Kenneth C. Frazier - $2.00M in EIKN purchases and sales in the last 12 months
- Foresite Capital Management IV, LLC - $1000K in EIKN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Josh Wolfe?
Josh Wolfe is a corporate insider of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Josh Wolfe last file a Form 4?
The only primary Form 4 on record is dated 6 February 2026.
Has Josh Wolfe been buying or selling stock?
Recorded transactions: 2 open-market purchases ($5.00M) and 0 open-market sales across all tracked filings.
